share_log

科济药业-B(02171.HK)拟3月26日举行董事会会议批准全年业绩

Keji Pharmaceutical-B (02171.HK) plans to hold a board meeting on March 26 to approve the annual results

Gelonghui Finance ·  Mar 12 04:40

Gelonghui March 12 | Keji Pharmaceutical-B (02171.HK) issued an announcement. The board of directors announced that a board meeting will be held on March 26, 2024 (Tuesday) to consider and approve the Group's annual results for the year ended 31 December 2023, and to deal with other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment